Total Costs & Expenses

$49.28B

Quarterly · Period ending: Sep 30, 2026 · USD

ELV Total Costs & Expenses

Latest reported$49.28Bperiod endingSep 30, 2026

ELV Quarterly Total Costs & Expenses ($0.00 → $49.28B)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

ELV total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elevance Health Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Sep 30, 2026	49,277,000,000
Jun 30, 2026	48,411,000,000
Mar 31, 2026	47,520,000,000
Dec 31, 2025	49,166,000,000
Sep 30, 2025	48,954,000,000
Jun 30, 2025	47,143,000,000
Mar 31, 2025	45,750,000,000
Dec 31, 2024	44,496,000,000
Sep 30, 2024	43,433,000,000
Jun 30, 2024	40,620,000,000
Mar 31, 2024	39,373,000,000
Dec 31, 2023	41,387,000,000
Sep 30, 2023	40,936,000,000
Jun 30, 2023	40,970,000,000
Mar 31, 2023	39,302,000,000
Dec 31, 2022	38,655,000,000
Sep 30, 2022	37,599,000,000
Jun 30, 2022	36,302,000,000
Mar 31, 2022	35,588,000,000
Dec 31, 2021	34,987,000,000
Sep 30, 2021	33,625,000,000
Jun 30, 2021	31,288,000,000
Mar 31, 2021	30,017,000,000
Dec 31, 2020	31,020,000,000
Sep 30, 2020	30,541,000,000
Jun 30, 2020	25,911,000,000
Mar 31, 2020	27,337,000,000
Dec 31, 2019	26,116,000,000
Sep 30, 2019	25,000,000,000
Jun 30, 2019	23,829,000,000
Mar 31, 2019	22,535,000,000
Dec 31, 2018	22,647,000,000
Sep 30, 2018	21,822,000,000
Jun 30, 2018	21,249,400,000
Mar 31, 2018	20,553,900,000
Dec 31, 2017	22,110,100,000
Sep 30, 2017	21,156,600,000
Jun 30, 2017	21,011,600,000
Mar 31, 2017	-20,775,900,000
Dec 31, 2016	-20,878,500,000
Sep 30, 2016	-20,068,500,000
Jun 30, 2016	20,007,900,000
Mar 31, 2016	18,976,500,000
Dec 31, 2015	19,813,600,000
Sep 30, 2015	18,772,000,000
Jun 30, 2015	18,457,500,000
Mar 31, 2015	17,482,400,000
Dec 31, 2014	18,097,200,000
Sep 30, 2014	17,469,800,000
Jun 30, 2014	17,209,700,000
Mar 31, 2014	16,729,300,000
Dec 31, 2013	17,111,100,000
Sep 30, 2013	16,975,800,000
Jun 30, 2013	16,482,200,000
Mar 31, 2013	16,293,500,000
Dec 31, 2012	15,054,700,000
Sep 30, 2012	14,327,400,000
Jun 30, 2012	14,358,700,000
Mar 31, 2012	14,105,400,000
Dec 31, 2011	14,839,500,000
Sep 30, 2011	14,352,800,000
Jun 30, 2011	14,093,300,000
Mar 31, 2011	13,467,200,000
Dec 31, 2010	13,895,800,000
Sep 30, 2010	13,435,500,000
Jun 30, 2010	13,301,700,000
Mar 31, 2010	13,737,600,000
Dec 31, 2009	14,706,800,000
Sep 30, 2009	14,307,900,000
Jun 30, 2009	14,360,700,000
Mar 31, 2009	14,249,700,000
Dec 31, 2008	14,561,800,000
Sep 30, 2008	14,411,600,000
Jun 30, 2008	14,480,800,000
Mar 31, 2008	14,674,500,000
Dec 31, 2007	14,238,600,000
Sep 30, 2007	13,870,600,000
Jun 30, 2007	13,950,600,000
Mar 31, 2007	13,841,600,000
Dec 31, 2006	13,271,700,000
Sep 30, 2006	13,194,800,000
Jun 30, 2006	12,967,800,000
Mar 31, 2006	12,665,800,000
Dec 31, 2005	10,390,900,000
Sep 30, 2005	10,133,500,000
Jun 30, 2005	10,252,400,000
Mar 31, 2005	10,014,200,000
Dec 31, 2004	6,520,100,000
Sep 30, 2004	4,434,800,000
Jun 30, 2004	4,245,300,000
Mar 31, 2004	4,182,900,000
Dec 31, 2003	3,967,100,000
Sep 30, 2003	3,951,600,000
Jun 30, 2003	3,835,800,000
Mar 31, 2003	3,797,800,000
Dec 31, 2002	3,721,000,000
Sep 30, 2002	3,350,000,000
Jun 30, 2002	2,740,800,000
Mar 31, 2002	17,600,000
Dec 31, 2001	2,524,400,000